Literature DB >> 22125331

Associations between first and second primary cancers: a population-based study.

Sune F Nielsen1, Børge G Nordestgaard, Stig E Bojesen.   

Abstract

BACKGROUND: Patients surviving certain types of cancer are at increased risk of a second primary cancer. We tested the hypothesis that excess risk of a second primary cancer is due mainly to excess risk of it being the same type of cancer as the first, rather than to excess risk of it being a different type.
METHODS: We conducted a nationwide study using data from three dabatases for the entire Danish population (n = 7,493,705) from 1980 through 2007. For each type of cancer, we performed a nested study matching each patient with incident cancer diagnosed in that period with up to five controls who did not have the examined cancer at the time of diagnosis. We used Cox regression models to calculate individual risk estimates and meta-analysis techniques to calculate aggregated risk estimates.
RESULTS: A total of 765,255 people had one or more diagnoses of primary cancer (total 843,118 diagnoses) during the study period. The aggregated hazard ratio (HR) for risk of any second primary cancer after any first cancer was 1.25 (95% confidence interval [CI] 1.24-1.26), with heterogeneity among cancer types. The aggregated HR for risk of a second primary cancer of the same type as the first was 2.16 (95% CI 1.98-2.34). The aggregated HR for risk of a second cancer of a different type from the first was 1.13 (95% CI 1.12-1.15). Results were similar when we excluded second primary cancers occurring within 1, 2, 5 or 10 years after the first cancer. Overall, we observed 74 significant associations among 27 types of first cancer and 27 possible types of second primary cancer.
INTERPRETATION: Excess risk of a second primary cancer was due mainly to a 2.2-fold risk of the second cancer being the same type as the first, whereas the risk of it being a different type was only 1.1-fold. However, heterogeneity among cancer types was substantial.

Entities:  

Mesh:

Year:  2011        PMID: 22125331      PMCID: PMC3255183          DOI: 10.1503/cmaj.110167

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  15 in total

1.  Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996.

Authors:  C Dong; K Hemminki
Journal:  Int J Cancer       Date:  2001-07-15       Impact factor: 7.396

2.  Risk of a new primary cancer among patients with lung cancer of different histological types.

Authors:  L Teppo; E Salminen; E Pukkala
Journal:  Eur J Cancer       Date:  2001-03       Impact factor: 9.162

3.  Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer.

Authors:  Diana S M Buist; Linn A Abraham; William E Barlow; Arun Krishnaraj; Regan C Holdridge; Edward A Sickles; Patricia A Carney; Karla Kerlikowske; Berta M Geller
Journal:  Breast Cancer Res Treat       Date:  2010-08-11       Impact factor: 4.872

4.  Second primary cancers after sporadic and familial colorectal cancer.

Authors:  K Hemminki; X Li; C Dong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-07       Impact factor: 4.254

5.  Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.

Authors:  Jørgen H Olsen; Torgil Möller; Harald Anderson; Frøydis Langmark; Risto Sankila; Laufey Tryggvadóttír; Jeanette Falck Winther; Catherine Rechnitzer; Gudmundur Jonmundsson; Jane Christensen; Stanislaw Garwicz
Journal:  J Natl Cancer Inst       Date:  2009-05-26       Impact factor: 13.506

6.  Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.

Authors:  Fabio Levi; Lalao Randimbison; Van-Cong Te; Manuela Maspoli Conconi; Carlo La Vecchia
Journal:  Int J Cancer       Date:  2008-12-15       Impact factor: 7.396

7.  Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.

Authors:  Milena Maule; Ghislaine Scélo; Guido Pastore; Paul Brennan; Kari Hemminki; Elizabeth Tracey; Risto Sankila; Elisabete Weiderpass; Jorgen H Olsen; Mary L McBride; David H Brewster; Vera Pompe-Kirn; Erich V Kliewer; Kee Seng Chia; Jon M Tonita; Carmen Martos; Jon G Jonasson; Franco Merletti; Paolo Boffetta
Journal:  J Natl Cancer Inst       Date:  2007-05-16       Impact factor: 13.506

8.  Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family.

Authors:  Laufey T Amundadottir; Sverrir Thorvaldsson; Daniel F Gudbjartsson; Patrick Sulem; Kristleifur Kristjansson; Sigurdur Arnason; Jeffrey R Gulcher; Johannes Bjornsson; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  PLoS Med       Date:  2004-12-28       Impact factor: 11.069

9.  Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.

Authors:  A Berrington de Gonzalez; R E Curtis; E Gilbert; C D Berg; S A Smith; M Stovall; E Ron
Journal:  Br J Cancer       Date:  2009-11-24       Impact factor: 7.640

10.  Multiple primary cancers in Denmark 1943-80; influence of possible underreporting and suggested risk factors.

Authors:  H H Storm; E Lynge; A Osterlind; O M Jensen
Journal:  Yale J Biol Med       Date:  1986 Sep-Oct
View more
  14 in total

1.  Enhancing a cancer prevention and control curriculum through interactive group discussions.

Authors:  L P Forsythe; S M Gadalla; J G Hamilton; B M Heckman-Stoddard; E E Kent; G Y Lai; S W Lin; P Luhn; J M Faupel-Badger
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

2.  Variation in risk of second primary cancer.

Authors:  Marcy Winget; Yutaka Yasui
Journal:  CMAJ       Date:  2011-11-28       Impact factor: 8.262

3.  Incidence of second primary cancers in North Portugal-a population-based study.

Authors:  Luís Pacheco-Figueiredo; Luís Antunes; Maria José Bento; Nuno Lunet
Journal:  J Cancer Surviv       Date:  2015-07-10       Impact factor: 4.442

4.  Survival of de novo stage IV breast cancer patients over three decades.

Authors:  Dieter Hölzel; Renate Eckel; Ingo Bauerfeind; Bernd Baier; Thomas Beck; Michael Braun; Johannes Ettl; Ulrich Hamann; Nadia Harbeck; Marion Kiechle; Sven Mahner; Christian Schindlbeck; Johann de Waal; Jutta Engel
Journal:  J Cancer Res Clin Oncol       Date:  2016-11-16       Impact factor: 4.553

5.  Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.

Authors:  Joanne Ngeow; Kim Stanuch; Jessica L Mester; Jill S Barnholtz-Sloan; Charis Eng
Journal:  J Clin Oncol       Date:  2014-04-28       Impact factor: 44.544

Review 6.  Management of cancer survivors in clinical and public health perspectives: current status and future challenges in Korea.

Authors:  Dong Wook Shin; BeLong Cho; So Young Kim; Je Hyuck Jung; Jong Hyock Park
Journal:  J Korean Med Sci       Date:  2013-05-02       Impact factor: 2.153

7.  Tumor necrosis factor-alpha gene promoter -308 and -238 polymorphisms in patients with lung cancer as a second primary tumor.

Authors:  Veljko Flego; Smiljana Ristić; Sanja Dević Pavlić; Dubravka Matanić Lender; Ljiljana Bulat-Kardum; Miljenko Kapović; Andjelka Radojčić Badovinac
Journal:  Med Sci Monit       Date:  2013-10-11

8.  A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects.

Authors:  Hao Liu; Kari Hemminki; Jan Sundquist; Bernd Holleczek; Alexander Katalinic; Katharina Emrich; Lina Jansen; Hermann Brenner
Journal:  Cancer Med       Date:  2013-08-27       Impact factor: 4.452

9.  Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries.

Authors:  Tianhui Chen; Mahdi Fallah; Hermann Brenner; Lina Jansen; Elias K Mai; Felipe A Castro; Alexander Katalinic; Katharina Emrich; Bernd Holleczek; Karla Geiss; Andrea Eberle; Kristina Sundquist; Kari Hemminki
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

10.  Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.

Authors:  Unhee Lim; Jonathan M Kocarnik; William S Bush; Tara C Matise; Christian Caberto; Sungshim Lani Park; Christopher S Carlson; Ewa Deelman; David Duggan; Megan Fesinmeyer; Christopher A Haiman; Brian E Henderson; Lucia A Hindorff; Laurence N Kolonel; Ulrike Peters; Daniel O Stram; Maarit Tiirikainen; Lynne R Wilkens; Chunyuan Wu; Charles Kooperberg; Loïc Le Marchand
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.